Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma

被引：1
|
作者：
Xu, Chang [1 ]
Studer, Ally [1 ]
Chen, Xueyan [1 ]
Hoyle, Eric [1 ]
Wu, David [1 ]
Mao, Zhengwei [1 ]
Wood, Brent L. [1 ]
机构：
[1] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131360
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1475
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia
    Germano, Giuseppe
    Valsecchi, Maria Grazia
    Buldini, Barbara
    Cazzaniga, Giovanni
    Zanon, Carlo
    Silvestri, Daniela
    te Kronnie, Geertruij
    Basso, Giuseppe
    Paganin, Maddalena
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 (01)
  • [2] Detection of Fusion Genes to Determine Minimal Residual Disease in Leukemia Using Next-Generation Sequencing
    de Boer, Eddy N.
    Johansson, Lennart F.
    de Lange, Kim
    Bosga-Brouwer, Anneke G.
    van den Berg, Eva
    Sikkema-Raddatz, Birgit
    van Diemen, Cleo C.
    [J]. CLINICAL CHEMISTRY, 2020, 66 (08) : 1084 - 1092
  • [3] Prognostic Value of Next Generation Sequencing in the Evaluation of Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia
    Bozhinovkj, Elizabeta Krstevska
    Matevska-Geshkovska, Nadica
    Stojovska, Marija Staninova
    Teov, Bojan
    Jovanovska, Aleksandra
    Kocheva, Svetlana
    Dimovski, Aleksandar
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 584 - 585
  • [4] Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia
    Della Starza, Irene
    De Novi, Lucia Anna
    Santoro, Alessandra
    Salemi, Domenico
    Tam, Wayne
    Cavalli, Marzia
    Menale, Lucia
    Soscia, Roberta
    Apicella, Valerio
    Ilari, Caterina
    Vitale, Antonella
    Testi, Anna Maria
    Inghirami, Giorgio
    Chiaretti, Sabina
    Foa, Robin
    Guarini, Anna
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (11) : 2838 - 2840
  • [5] Clinical Utility of Next-Generation Sequencing-Based Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
    Sekiya, Yuko
    Okuno, Yusuke
    Muramatsu, Hideki
    Narita, Atsushi
    Suzuki, Kyogo
    Wang, Xinan
    Kawashima, Nozomu
    Xu, Yinyan
    Sakaguchi, Hirotoshi
    Yoshida, Nao
    Hama, Asahito
    Takahashi, Yoshiyuki
    Kato, Koji
    Kojima, Seiji
    [J]. BLOOD, 2015, 126 (23)
  • [6] Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia
    Shin, Saeam
    Hwang, In Sik
    Kim, Jieun
    Lee, Kyung-A
    Lee, Seung-Tae
    Choi, Jong Rak
    [J]. ANNALS OF LABORATORY MEDICINE, 2017, 37 (04) : 331 - 335
  • [7] Integration of Next-Generation Sequencing in Diagnosing and Minimal Residual Disease Detection in Patients With Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
    Sherali, Nazleen
    Hamadneh, Tariq
    Aftab, Saba
    Alfonso, Michael S.
    Tsouklidis, Nicholas
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [8] Next-Generation Sequencing and Detection of Minimal Residual Disease in Acute Myeloid Leukemia Ready for Clinical Practice?
    Pastore, Friederike
    Levine, Ross L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (08): : 778 - 780
  • [9] Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
    Michaela Kotrova
    Jan Trka
    Michael Kneba
    Monika Brüggemann
    [J]. Molecular Diagnosis & Therapy, 2017, 21 : 481 - 492
  • [10] Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
    Kotrova, Michaela
    Trka, Jan
    Kneba, Michael
    Brueggemann, Monika
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (05) : 481 - 492
12345